Salvage Management of Vestibular Schwannoma.

Functional outcomes Microsurgery Revisions Stereotactic radiosurgery Treatment failures Vestibular schwannomas

Journal

Otolaryngologic clinics of North America
ISSN: 1557-8259
Titre abrégé: Otolaryngol Clin North Am
Pays: United States
ID NLM: 0144042

Informations de publication

Date de publication:
Jun 2023
Historique:
medline: 2 5 2023
pubmed: 25 3 2023
entrez: 24 3 2023
Statut: ppublish

Résumé

The current management of vestibular schwannomas (VS) includes observation, microsurgery (MS), and stereotactic radiosurgery (SRS) or radiotherapy, and treatment failures may occur with any primary modality. SRS is most often used for microsurgical failures, as it carries a low risk of adverse events. Salvage MS following previous MS is reserved for specific cases and can present certain surgical challenges. Irradiation failures can be managed with both salvage MS and repeat SRS. This article is intended to review an approach to the failure of primary interventions for VS, with a focus on the time interval between modalities, rates of tumor control, functional outcomes, and possible complications.

Identifiants

pubmed: 36964093
pii: S0030-6665(23)00036-1
doi: 10.1016/j.otc.2023.02.014
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

557-565

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Auteurs

Emily Kay-Rivest (E)

Division of Otology and Neurotology, Department of Otolaryngology-Head and Neck Surgery, McGill University, Montreal, Quebec, Canada; Division of Otology and Neurotology, Department of Otolaryngology-Head and Neck Surgery, New York University, New York, NY, USA. Electronic address: Emily.kay-rivest@mcgill.ca.

John Thomas Roland (JT)

Division of Otology and Neurotology, Department of Otolaryngology-Head and Neck Surgery, New York University, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH